Prognostic significance of preoperative serum CEA in primary mucinous ovarian carcinoma: a retrospective cohort study

References

• JangJYAYanaiharaNPujade-LauraineEUpdate on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator ConferenceJ Gynecol Oncol2017284e5428541641
   PubMed Web of Science ®Google Scholar
• MuellerJJLajerHMosgaardBJInternational study of primary mucinous ovarian carcinomas managed at tertiary medical centersInt J Gynecol Cancer201828591592429561302
   PubMed Web of Science ®Google Scholar
• HessVA’HernRNasiriNMucinous epithelial ovarian cancer: a separate entity requiring specific treatmentJ Clin Oncol20042261040104415020606
   PubMed Web of Science ®Google Scholar
• SchiavoneMBHerzogTJLewinSNNatural history and outcome of mucinous carcinoma of the ovaryAm J Obstet Gynecol20112055480.e1480.e821861962
   PubMed Web of Science ®Google Scholar
• SimonsMEzendamNBultenJNagtegaalIMassugerLSurvival of patients with mucinous ovarian carcinoma and ovarian metastasesInt J Gynecol Cancer20152571208121525978291
   PubMed Web of Science ®Google Scholar
• LedermannJARajaFAFotopoulouCNewly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201324Suppl 6vi24vi3224078660
   PubMed Web of Science ®Google Scholar
• SteffensenKDWaldstrømMBrandslundIJakobsenAPrognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patientsInt J Gynecol Cancer20112161040104721738039
   PubMed Web of Science ®Google Scholar
• TangAKondalsamy-ChennakesavanSNganHPrognostic value of elevated preoperative serum CA125 in ovarian tumors of low malignant potential: a multinational collaborative study (ANZGOG0801)Gynecol Oncol20121261364022370601
   PubMed Web of Science ®Google Scholar
• BastRCUrbanNShridharVEarly detection of ovarian cancer: promise and realityCancer Treat Res2002107619711775462
   PubMedGoogle Scholar
• HarrisonMLJamesonCGoreMEMucinous ovarian cancerInt J Gynecol Cancer200818220921417624989
   PubMed Web of Science ®Google Scholar
• DuffyMJLamerzRHaglundCTumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateInt J Cancer2014134112513252223852704
   PubMed Web of Science ®Google Scholar
• ParkBWOhJWKimJHPreoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomesAnn Oncol200819467568118037623
   PubMed Web of Science ®Google Scholar
• OkadaMNishioWSakamotoTPrognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I diseaseAnn Thorac Surg200478121622115223432
   PubMed Web of Science ®Google Scholar
• KochiMFujiiMKanamoriNEvaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancerGastric Cancer20003417718611984734
   PubMedGoogle Scholar
• KurmanRJCarcangjuMLHerringtonCSYoungRHWHO Classification of Tumours of Female Reproductive Organs4th edLyonIARC2014
   Google Scholar
• LedermannJALuveroDShaferAGynecologic Cancer Inter-Group (GCIG) consensus review for mucinous ovarian carcinomaInt J Gynecol Cancer2014249 Suppl 3S14S1925341574
   PubMed Web of Science ®Google Scholar
• VangRGownAMWuLSImmunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7Mod Pathol200619111421142816980943
   PubMed Web of Science ®Google Scholar
• PratJFIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneumInt J Gynaecol Obstet201412411524219974
   PubMed Web of Science ®Google Scholar
• MorganRJCopelandLGershensonDNCCN Ovarian Cancer Practice Guidelines. The National Comprehensive Cancer NetworkOncology19961011 Suppl2933108953610
   PubMedGoogle Scholar
• MorganRJAlvarezRDArmstrongDKOvarian cancer, version 3.2012J Natl Compr Canc Netw201210111339134923138163
   PubMed Web of Science ®Google Scholar
• MorganRJAlvarezRDArmstrongDKOvarian cancer, version 2.2013J Natl Compr Canc Netw201311101199120924142821
   PubMed Web of Science ®Google Scholar
• MorganRJArmstrongDKAlvarezRDOvarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in OncologyJ Natl Compr Canc Netw20161491134116327587625
   PubMed Web of Science ®Google Scholar
• ShimadaMKigawaJOhishiYClinicopathological characteristics of mucinous adenocarcinoma of the ovaryGynecol Oncol2009113333133419275957
   PubMed Web of Science ®Google Scholar
• SeidmanJDKurmanRJRonnettBMPrimary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosisAm J Surg Pathol200327798599312826891
   PubMed Web of Science ®Google Scholar
• KhunamornpongSSuprasertPPojchamarnwiputhSNa ChiangmaiWSettakornJSiriaunkgulSPrimary and metastatic mucinous adenocarcinomas of the ovary: Evaluation of the diagnostic approach using tumor size and lateralityGynecol Oncol2006101115215716300822
   PubMed Web of Science ®Google Scholar
• YemelyanovaAVVangRJudsonKWuLSRonnettBMDistinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classificationAm J Surg Pathol200832112813818162780
   PubMed Web of Science ®Google Scholar
• GoldPFreedmanSOSpecific carcinoembryonic antigens of the human digestive systemJ Exp Med196512234674814953873
   PubMed Web of Science ®Google Scholar
• TsaiCCLinHHuangEYThe role of the preoperative serum carcinoembryonic antigen level in early-stage adenocarcinoma of the uterine cervixGynecol Oncol200494236336715297173
   PubMed Web of Science ®Google Scholar
• KhooSKMackayEVCarcinoembryonic antigen (CEA) in ovarian cancer: factors influencing its incidence and changes which occur in response to cytotoxic drugsBr J Obstet Gynaecol19768310753759990213
   PubMedGoogle Scholar
• TholanderBTaubeALindgrenASjöbergOStendahlUTamsenLPretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of diseaseGynecol Oncol199039126332227570
   PubMed Web of Science ®Google Scholar
• MassadLSGaoFHagemannIPowellMClinical Outcomes among Women with Mucinous Adenocarcinoma of the OvaryGynecol Obstet Invest201681541141526583769
   PubMed Web of Science ®Google Scholar
• NickAMColemanRLRamirezPTSoodAKA framework for a personalized surgical approach to ovarian cancerNat Rev Clin Oncol201512423924525707631
   PubMed Web of Science ®Google Scholar
• WuSGHeZYRenHYUse of CEA and CA15-3 to predict axillary lymph node metastasis in patients with breast cancerJ Cancer201671374126722358
   PubMed Web of Science ®Google Scholar
• HuangEYHuangYJChanchienCCPretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervixRadiat Oncol201271322289572
   PubMed Web of Science ®Google Scholar
• TrimbosJBParmarMVergoteIInternational Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinomaJ Natl Cancer Inst200395210511212529343
   PubMed Web of Science ®Google Scholar
• AlexandreJRay-CoquardISelleFMucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experienceAnn Oncol201021122377238120494964
   PubMed Web of Science ®Google Scholar